nach oben

Erschienen in:

2020 | OriginalPaper | Buchkapitel

2. Epidemiologie der chronisch-entzündlichen Darmerkrankungen

verfasst von : Antje Timmer

Erschienen in: Chronisch-entzündliche Darmerkrankungen

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Epidemiologie befasst sich zum einen mit der Häufigkeit von Erkrankungen, zum anderen mit der Identifikation von Faktoren, die mit dem Erkrankungsrisiko in Zusammenhang stehen. Bei Erkrankungen mit unklarer Ätiologie, zu denen die chronisch-entzündlichen Darmerkrankungen (CED) weiterhin zu zählen sind, sollen epidemiologischen Studien v. a. hilfreiche Anhaltspunkte zu möglichen kausalen Faktoren liefern. Epidemiologische Daten bilden zudem die Grundlage für Versorgungsforschung und -planung, aber auch für die Optimierung klinischer Studien.

Abraham BP, Mehta S, El-Serag HB (2012) Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol 46:581–589PubMedPubMedCentral

Adami HO, Bretthauer M, Emilsson L, Hernan MA, Kalager M, Ludvigsson JF, Ekbom A (2016) The continuing uncertainty about cancer risk in inflammatory bowel disease. Gut 65:889–893PubMedPubMedCentral

Afzali A, Cross RK (2016) Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences. Inflamm Bowel Dis 22:2023–2040PubMed

Aldhous MC, Drummond HE, Anderson N, Smith LA, Arnott ID, Satsangi J (2007) Does cigarette smoking influence the phenotype of Crohn’s disease? Analysis using the Montreal classification. Am J Gastroenterol 102:577–588PubMed

Alexakis C, Kumar S, Saxena S, Pollok R (2017) Systematic review with meta-analysis: the impact of a depressive state on disease course in adult inflammatory bowel disease. Aliment Pharmacol Ther 46:225–235PubMed

Amre DK, D’Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, Israel D, Mack D, Ghadirian P, Deslandres C et al (2007) Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn’s disease in children. Am J Gastroenterol 102:2016–2025PubMed

Ananthakrishnan AN (2015) Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci 60:290–298PubMed

Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT (2012) Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology 142:482–489PubMed

Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT (2013a) A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology 145:970–977PubMedPubMedCentral

Ananthakrishnan AN, Khalili H, Pan A, Higuchi LM, de Silva P, Richter JM, Fuchs CS, Chan AT (2013b) Association between depressive symptoms and incidence of Crohn’s disease and ulcerative colitis: results from the Nurses‘ Health Study. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 11:57–62

Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Richter JM, Schernhammer ES, Chan AT (2014) Sleep duration affects risk for ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 12:1879–1886

Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Richter JM, Chan AT (2015a) Zinc intake and risk of Crohn’s disease and ulcerative colitis: a prospective cohort study. Int J Epidemiol 44:1995–2005PubMedPubMedCentral

Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Richter JM, Nimptsch K, Wu K, Chan AT (2015b) High school diet and risk of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis 21:2311–2319PubMedPubMedCentral

Andersen V, Chan S, Luben R, Khaw KT, Olsen A, Tjonneland A, Kaaks R, Grip O, Bergmann MM, Boeing H et al (2018) Fibre intake and the development of inflammatory bowel disease: a European prospective multi-centre cohort study (EPIC-IBD). J Crohn’s Colitis 12:129–136

Annese V, Duricova D, Gower-Rousseau C, Jess T, Langholz E (2016) Impact of new treatments on hospitalisation, surgery, infection, and mortality in IBD: a focus paper by the Epidemiology Committee of ECCO. J Crohn’s Colitis 10:216–225

Araki M, Shinzaki S, Yamada T, Arimitsu S, Komori M, Shibukawa N, Mukai A, Nakajima S, Kinoshita K, Kitamura S et al (2017) Age at onset is associated with the seasonal pattern of onset and exacerbation in inflammatory bowel disease. J Gastroenterol 52:1149–1157PubMed

Archer R, Tappenden P, Ren S, Martyn-St James M, Harvey R, Basarir H, Stevens J, Carroll C, Cantrell A, Lobo A et al (2016) Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model. Health Technol Assess (Winchester, England) 20:1–326

Bahler C, Vavricka SR, Schoepfer AM, Brungger B, Reich O (2017) Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014. BMC Gastroenterol 17:138PubMedPubMedCentral

Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S et al (2005) Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 54:357–363PubMedPubMedCentral

Basson A, Swart R, Jordaan E, Mazinu M, Watermeyer G (2014) The association between childhood environmental exposures and the subsequent development of Crohn’s disease in the Western Cape, South Africa. PLoS ONE 9:e115492PubMedPubMedCentral

Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J (2001) Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 96:2113–2116PubMed

Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM (2011) Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 17:423–439PubMed

Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Singh H, Otley AR, Vutcovici M, El-Matary W, Nguyen GC, Griffiths AM et al (2017a) Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases. Am J Gastroenterol 112:1120–1134PubMedPubMedCentral

Benchimol EI, Kaplan GG, Otley AR, Nguyen GC, Underwood FE, Guttmann A, Jones JL, Potter BK, Catley CA, Nugent ZJ et al (2017b) Rural and urban residence during early life is associated with risk of inflammatory bowel disease: a population-based inception and birth cohort study. Am J Gastroenterol 112:1412–1422PubMedPubMedCentral

Bequet E, Sarter H, Fumery M, Vasseur F, Armengol-Debeir L, Pariente B, Ley D, Spyckerelle C, Coevoet H, Laberenne JE et al (2017) Incidence and phenotype at diagnosis of very-early-onset compared with later-onset paediatric inflammatory bowel disease: a population-based study [1988–2011]. J Crohn’s Colitis 11:519–526

Bergmann MM, Hernandez V, Bernigau W, Boeing H, Chan SS, Luben R, Khaw KT, van Schaik F, Oldenburg B, Bueno-de-Mesquita B et al (2017) No association of alcohol use and the risk of ulcerative colitis or Crohn’s disease: data from a European Prospective cohort study (EPIC). Eur J Clin Nutr 71:512–518PubMed

Bernell O, Lapidus A, Hellers G (2000) Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn’s disease. Br J Surg 87:1697–1701PubMed

Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, Schulz T, Stray N, Vatn M, Moum B (2006) Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 12:402–412PubMed

Bernstein CN, Kraut A, Blanchard JF, Rawsthorne P, Yu N, Walld R (2001) The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol 96:2117–2125PubMed

Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, Fedorak R, Israel D, Blanchard JF (2006) The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 101:1559–1568PubMed

Bernstein CN, Rawsthorne P, Blanchard JF (2007) Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease. Inflamm Bowel Dis 13:759–762PubMed

Bernstein CN, Nugent Z, Targownik LE, Singh H, Lix LM (2015) Predictors and risks for death in a population-based study of persons with IBD in Manitoba. Gut 64:1403–1411PubMed

Bitton A, Vutcovici M, Patenaude V, Sewitch M, Suissa S, Brassard P (2014) Epidemiology of inflammatory bowel disease in Quebec: recent trends. Inflamm Bowel Dis 20:1770–1776PubMed

Bitton A, Vutcovici M, Sewitch M, Suissa S, Brassard P (2016) Mortality trends in Crohn’s disease and ulcerative colitis: a population-based study in Quebec, Canada. Inflamm Bowel Dis 22:416–423PubMed

Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P, Epidemiol AJ (2001) Small-area variations and sociodemographic correlates for the incidence of Crohn’s disease and ulcerative colitis. Am J Epidemiol 154:328–335PubMed

Blumenstein I, Bock H, Weber C, Rambow A, Tacke W, Kihn R, Pfaff R, Orlemann S, Schaeffer R, Schroder O et al (2008) Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study. IBD 14:53–60

Blumenstein I, Tacke W, Filmann N, Zosel C, Bock H, Heuzeroth V, Zeuzem S, Schroder O (2013) Integrated management of patients with chronic inflammatory bowel disease in the Rhine-Main region: results of the first integrated health-care project IBD in Germany. Z Gastroenterol 51:613–618PubMed

Boonen A, Dagnelie PC, Feleus A, Hesselink MA, Muris JW, Stockbrugger RW, Russel MG (2002) The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis 8:382–389PubMed

Braegger CP, Ballabeni P, Rogler D, Vavricka SR, Friedt M, Pittet V (2011) Epidemiology of inflammatory bowel disease: is there a shift towards onset at a younger age? J Pediatr Gastroenterol Nutr 53:141–144PubMed

Brandes JW, Lorenz-Meyer H (1983) Epidemiologische Aspekte zur Enterocolitis regionalis Crohn und Colitis ulcerosa in Marburg/Lahn (FRG) zwischen 1962 und 1975 [Epidemiological aspects of enterocolitis regionalis Crohn and colitis ulcerosa in Marburg/Lahn (FRG) from 1962 to 1975][German]. Z Gastroenterol 21:69–78PubMed

Buderus S, Scholz D, Behrens R, Classen M, De Laffolie J, Keller KM, Zimmer KP, Koletzko S (2015) Inflammatory bowel disease in pediatric patients: characteristics of newly diagnosed patients from the CEDATA-GPGE registry. Dtsch Arztebl Int 112:121–127PubMedPubMedCentral

Burisch J, Jess T, Martinato M, Lakatos PL (2013) The burden of inflammatory bowel disease in Europe. J Crohn’s Colitis 7:322–337

Busch K, da Silva SA, Holton M, Rabacow FM, Khalili H, Ludvigsson JF (2014) Sick leave and disability pension in inflammatory bowel disease: a systematic review. J Crohn’s Colitis 8:1362–1377

Calkins BM (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34:1841–1854PubMed

Canavan C, Abrams KR, Hawthorne B, Mayberry JF (2007) Long-term prognosis in Crohn’s disease: an epidemiological study of patients diagnosed more than 20 years ago in Cardiff. Aliment Pharmacol Ther 25:59–65PubMed

Castano-Rodriguez N, Kaakoush NO, Lee WS, Mitchell HM (2017) Dual role of helicobacter and campylobacter species in IBD: a systematic review and meta-analysis. Gut 66:235–249PubMed

Chan SS, Luben R, Olsen A, Tjonneland A, Kaaks R, Lindgren S, Grip O, Bergmann MM, Boeing H, Hallmans G et al (2014) Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn’s disease. Aliment Pharmacol Ther 39:834–842PubMedPubMedCentral

Cholapranee A, Ananthakrishnan AN (2016) Environmental hygiene and risk of inflammatory bowel diseases: a systematic review and meta-analysis. Inflamm Bowel Dis 22:2191–2199PubMedPubMedCentral

Chu TPC, Moran GW, Card TR (2017) The pattern of underlying cause of death in patients with inflammatory bowel disease in England: a record linkage study. J Crohn’s Colitis 11:578–585

Click B, Ramos Rivers C, Koutroubakis IE, Babichenko D, Anderson AM, Hashash JG, Dunn MA, Schwartz M, Swoger J, Baidoo L et al (2016) Demographic and clinical predictors of high healthcare use in patients with inflammatory bowel disease. Inflamm Bowel Dis 22:1442–1449PubMedPubMedCentral

Cohen RD, Yu AP, Wu EQ, Xie J, Mulani PM, Chao J (2010) Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther 31:693–707PubMed

Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, Di Paolo M, Riegler G, Rigo GP, Ferrau O et al (1998) Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol 27:397–404

Cosnes J, Beaugerie L, Carbonnel F, Gendre JP (2001) Smoking cessation and the course of Crohn’s disease: an intervention study. Gastroenterology 120:1093–1099PubMed

D’Souza S, Levy E, Mack D, Israel D, Lambrette P, Ghadirian P, Deslandres C, Morgan K, Seidman EG, Amre DK (2008) Dietary patterns and risk for Crohn’s disease in children. IBD 14:367–373

Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB (2016) Prevalence of inflammatory bowel disease among adults aged >/=18 years – United States, 2015. MMWR Morb Mortal Wkly Rep 65:1166–1169PubMed

Daiss W, Scheurle M, Malchow H (1989) Epidemiology of inflammatory bowel disease in the county of Tubingen (West Germany). Scand J Gastroenterol 170:39–43

de Groof EJ, Rossen NG, van Rhijn BD, Karregat EP, Boonstra K, Hageman I, Bennebroek Evertsz F, Kingma PJ, Naber AH, van den Brande JH et al (2016) Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the Netherlands. Eur J Gastroenterol Hepatol 28:1065–1072PubMed

Dong J, Chen Y, Tang Y, Xu F, Yu C, Li Y, Pankaj P, Dai N (2015) Body mass index is associated with inflammatory bowel disease: a systematic review and meta-analysis. PLoS ONE 10:e0144872PubMedPubMedCentral

Dorn SD, Sandler RS (2006) Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol 102(3):662

Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T (2010) Overall and cause-specific mortality in Crohn’s disease: a meta-analysis of population-based studies. Inflamm Bowel Dis 16:347–353PubMed

Duricova D, Burisch J, Jess T, Gower-Rousseau C, Lakatos PL (2014) Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohn’s Colitis 8:1351–1361

Duricova D, Fumery M, Annese V, Lakatos PL, Peyrin-Biroulet L, Gower-Rousseau C (2017) The natural history of Crohn’s disease in children: a review of population-based studies. Eur J Gastroenterol Hepatol 29:125–134PubMed

Ekbom A, Adami HO (1991) The epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 7:649–653

Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO (1992) Survival and causes of death in patients with inflammatory bowel disease: a population-based study. Gastroenterology 103:954–960PubMed

Eluri S, Cross RK, Martin C, Weinfurt KP, Flynn KE, Long MD, Chen W, Anton K, Sandler RS, Kappelman MD (2018) Inflammatory bowel diseases can adversely impact domains of sexual function such as satisfaction with sex life. Dig Dis Sci 63(6):1572–1582PubMedPubMedCentral

Fischer P, Richter T (2007) Inzidenz und Prävalenz chronisch entzündlicher Darmerkrankungen bei Kinder und Jugendlichen in Sachsen – eine Fünfjahresanalyse des Sächsischen Registers für Kinder mit CED. Kinder- Jugendmed 2:A2

Floyd DN, Langham S, Severac HC, Levesque BG (2015) The economic and quality-of-life burden of Crohn’s disease in Europe and the United States, 2000 to 2013: a systematic review. Dig Dis Sci 60:299–312PubMed

Fofanova TY, Petrosino JF, Kellermayer R (2016) Microbiome-epigenome interactions and the environmental origins of inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 62:208–219PubMedPubMedCentral

Freckmann M, Seipp A, Laass MW, Koletzko S, Claßen M, Ballauff A, Peplies J, Timmer A (2018) School related experience and performance with inflammatory bowel disease – results from a cross sectional survey in 675 children and their parents. BM Open Gastroenterol 5(1):e000236

Friedman MY, Leventer-Roberts M, Rosenblum J, Zigman N, Goren I, Mourad V, Lederman N, Cohen N, Matz E, Dushnitzky DZ et al (2018) Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study. Clin Epidemiol 10:671–681PubMedPubMedCentral

Fries W, Viola A, Manetti N, Frankovic I, Pugliese D, Monterubbianesi R, Scalisi G, Aratari A, Cantoro L, Cappello M et al (2017) Disease patterns in late-onset ulcerative colitis: results from the IG-IBD “AGED study”. Dig Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver 49:17–23

Frolkis AD, Dykeman J, Negron ME, Debruyn J, Jette N, Fiest KM, Frolkis T, Barkema HW, Rioux KP, Panaccione R et al (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 145:996–1006

Fumery M, Duricova D, Gower-Rousseau C, Annese V, Peyrin-Biroulet L, Lakatos PL (2016) Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies. Aliment Pharmacol Ther 43:346–355PubMed

Ganz ML, Sugarman R, Wang R, Hansen BB, Hakan-Bloch J (2016) The economic and health-related impact of Crohn’s disease in the United States: evidence from a nationally representative survey. Inflamm Bowel Dis 22:1032–1041PubMed

GBD 2015 DALYs and HALE Collaborators (2016) Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1603–1658

Gordon H, Langholz E (2017) The EpiCom survey-registries across Europe, epidemiological research and beyond. J Crohn’s Colitis 11:1019–1021

Hafner S, Timmer A, Herfarth H, Rogler G, Scholmerich J, Schaffler A, Ehrenstein B, Jilg W, Ott C, Strauch UG et al (2008) The role of domestic hygiene in inflammatory bowel diseases: hepatitis A and worm infestations. Eur J Gastroenterol Hepatol 20:561–566PubMed

Hammer T, Lophaven SN, Nielsen KR, von Euler-Chelpin M, Weihe P, Munkholm P, Burisch J, Lynge E (2017) Inflammatory bowel diseases in Faroese-born Danish residents and their offspring: further evidence of the dominant role of environmental factors in IBD development. Aliment Pharmacol Ther 45:1107–1114PubMedPubMedCentral

Heikkila K, Madsen IE, Nyberg ST, Fransson EI, Ahola K, Alfredsson L, Bjorner JB, Borritz M, Burr H, Dragano N et al (2014) Job strain and the risk of inflammatory bowel diseases: individual-participant meta-analysis of 95,000 men and women. PLoS ONE 9:e88711PubMedPubMedCentral

Hein R, Koster I, Bollschweiler E, Schubert I (2014) Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort. Scand J Gastroenterol 49:1325–1335PubMed

Higuchi LM, Khalili H, Chan AT, Richter JM, Bousvaros A, Fuchs CS (2012) A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol 107:1399–1406PubMedPubMedCentral

Hlavaty T, Krajcovicova A, Payer J (2015) Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much? J Crohn’s Colitis 9:198–209

Hoie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T, Odes S, Mouzas IA, Beltrami M, Langholz E et al (2007) Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 102:1692–1701PubMed

Holmes EA, Xiang F, Lucas RM (2015) Variation in incidence of pediatric Crohn’s disease in relation to latitude and ambient ultraviolet radiation: a systematic review and analysis. Inflamm Bowel Dis 21:809–817PubMed

Hugot JP, Alberti C, Berrebi D, Bingen E, Cezard JP (2003) Crohn’s disease: the cold chain hypothesis. Lancet 362:2012–2015PubMed

Huoponen S, Blom M (2015) A systematic review of the cost-effectiveness of biologics for the treatment of inflammatory bowel diseases. PLoS ONE 10:e0145087PubMedPubMedCentral

Janke KH, Raible A, Bauer M, Clemens P, Meisner C, Hauser W, Steder-Neukamm U, Henrich G, Herschbach P, Gregor M et al (2004) Questions on life satisfaction (FLZM) in inflammatory bowel disease. Int J Colorectal Dis 19:343–353PubMed

Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F (2010) Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol 105:2195–2201PubMed

Jess T, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ 3rd, Munkholm P, Sandborn WJ (2006) Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940–2004. Gut 55:1248–1254PubMedPubMedCentral

Jess T, Gamborg M, Munkholm P, Sorensen TI (2007) Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol 102:609–617PubMed

Jeuring SF, van den Heuvel TR, Zeegers MP, Hameeteman WH, Romberg-Camps MJ, Oostenbrug LE, Masclee AA, Jonkers DM, Pierik MJ (2016) Epidemiology and long-term outcome of inflammatory bowel disease diagnosed at elderly age – an increasing distinct entity? Inflamm Bowel Dis 22:1425–1434PubMed

John S, Luben R, Shrestha SS, Welch A, Khaw KT, Hart AR (2010) Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol 22:602–606PubMed

Joos S, Rosemann T, Szecsenyi J, Hahn EG, Willich SN, Brinkhaus B (2006) Use of complementary and alternative medicine in Germany – a survey of patients with inflammatory bowel disease. BMC Complement Altern Med 6:19PubMedPubMedCentral

Kaplan GG (2014) IBD: global variations in environmental risk factors for IBD. Nat Rev Gastroenterol Hepatol 11:708–709PubMed

Kaplan G (2018) Interactive maps (Worldwide incidence and prevalence of IBD), Ergänzendes Material zu Ng 2017, ed

Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson RE, Korzenik J (2008) The risk of developing Crohn’s disease after an appendectomy: a meta-analysis. Am J Gastroenterol 103:2925–2931PubMed

Kaplan GG, Hubbard J, Korzenik J, Sands BE, Panaccione R, Ghosh S, Wheeler AJ, Villeneuve PJ (2010) The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol 105:2412–2419PubMedPubMedCentral

Kawalec P (2016) Indirect costs of inflammatory bowel diseases: Crohn’s disease and ulcerative colitis. A systematic review. Arch Med Sci: AMS 12:295–302PubMed

Kawalec P, Malinowski KP (2015) Indirect health costs in ulcerative colitis and Crohn’s disease: a systematic review and meta-analysis. Expert Rev Pharmacoeconomics Outcomes Res 15:253–266

Kemp K, Griffiths J, Lovell K (2012) Understanding the health and social care needs of people living with IBD: a meta-synthesis of the evidence. World J Gastroenterol 18:6240–6249PubMedPubMedCentral

Khalili H, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, Spiegelman D, Richter JM, Korzenik JR, Chan AT (2013a) Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses‘ Health Study cohorts. BMJ (Clinical research ed) 347:f6633

Khalili H, Higuchi LM, Ananthakrishnan AN, Richter JM, Feskanich D, Fuchs CS, Chan AT (2013b) Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut 62:1153–1159PubMed

Koutroubakis IE, Vlachonikolis IG (2000) Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol 95:171–176PubMed

Kuenzig ME, Yim J, Coward S, Eksteen B, Seow CH, Barnabe C, Barkema HW, Silverberg MS, Lakatos PL, Beck PL et al (2017) The NOD2-smoking interaction in Crohn’s disease is likely specific to the 1007fs mutation and may be explained by age at diagnosis: a meta-analysis and case-only study. EBioMedicine 21:188–196PubMedPubMedCentral

Kuo CJ, Yu KH, See LC, Chiu CT, Su MY, Hsu CM, Kuo CF, Chiou MJ, Liu JR, Wang HW (2015) The trend of inflammatory bowel diseases in Taiwan: a population-based study. Dig Dis Sci 60:2454–2462PubMed

Lange A, Aumann I, Pauer F, von der Schulenburg JM (2018) Chronisch entzündliche Darmerkrankungen: Epidemiologie und Gesundheitsökonomie. In: Platz O (Hrsg) Weißbuch Gastroenterologische Erkrankungen 2018/19 (E-Book). Thieme, Stuttgart, S 1173–1184

Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V (1991) Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 26:1247–1256PubMed

Langholz E, Munkholm P, Davidsen M, Binder V (1994) Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 107:3–11PubMed

Lattimer LD, Chandler MB, Borum ML (2015) Hispanics and inflammatory bowel disease. Inflamm Bowel Dis 21:1214–1218PubMed

Leong RW, Mitrev N, Ko Y (2016) Hygiene hypothesis: is the evidence the same all over the world? Dig Dis (Basel, Switzerland) 34:35–42

Levine A, Sigall Boneh R, Wine E (2018) Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut 67:1726–1738PubMed

Lewis JD, Abreu MT (2017) Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology 152:398–414.e396PubMed

Lewis JD, Gelfand JM, Troxel AB, Forde KA, Newcomb C, Kim H, Margolis DJ, Strom BL (2008) Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol 103:1428–1435, quiz 1436PubMed

Lindsay JO, Bergman A, Patel AS, Alesso SM, Peyrin-Biroulet L (2015) Systematic review: the financial burden of surgical complications in patients with ulcerative colitis. Aliment Pharmacol Ther 41:1066–1078PubMed

Löffler A, Glados M (1993) Daten zur Epidemiologie des Morbus Crohn in der Grossstadt Köln [Data on the epidemiology of Crohn disease in the city of Cologne]. [German]. Med Klin 15:516–519

Lophaven SN, Lynge E, Burisch J (2017) The incidence of inflammatory bowel disease in Denmark 1980–2013: a nationwide cohort study. Aliment Pharmacol Ther 45:961–972PubMed

Lu Y, Zamora-Ros R, Chan S, Cross AJ, Ward H, Jakszyn P, Luben R, Opstelten JL, Oldenburg B, Hallmans G et al (2017) Dietary polyphenols in the aetiology of Crohn’s disease and ulcerative colitis – a multicenter European Prospective Cohort Study (EPIC). Inflamm Bowel Dis 23:2072–2082PubMed

Ma C, Moran GW, Benchimol EI, Targownik LE, Heitman SJ, Hubbard JN, Seow CH, Novak KL, Ghosh S, Panaccione R (2017) Surgical rates for Crohn’s disease are decreasing: a population-based time trend analysis and validation study. Am J Gastroenterol 112:1840PubMedPubMedCentral

Mackner LM, Bickmeier RM, Crandall WV (2012) Academic achievement, attendance, and school-related quality of life in pediatric inflammatory bowel disease. J Dev Behav Pediatr 33:106–111PubMed

Mahid SS, Minor KS, Stromberg AJ, Galandiuk S (2007) Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis 13:431–438PubMed

Malmborg P, Hildebrand H (2016) The emerging global epidemic of paediatric inflammatory bowel disease – causes and consequences. J Intern Med 279:241–258PubMed

Marri SR, Buchman AL (2005) The education and employment status of patients with inflammatory bowel diseases. Inflamm Bowel Dis 11:171–177PubMed

McGilligan VE, Wallace JM, Heavey PM, Ridley DL, Rowland IR (2007) Hypothesis about mechanisms through which nicotine might exert its effect on the interdependence of inflammation and gut barrier function in ulcerative colitis. IBD 13:108–115

Melinder C, Hiyoshi A, Fall K, Halfvarson J, Montgomery S (2017) Stress resilience and the risk of inflammatory bowel disease: a cohort study of men living in Sweden. BMJ Open 7:e014315PubMedPubMedCentral

Mikocka-Walus A, Knowles SR, Keefer L, Graff L (2016) Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis 22:752–762PubMed

Misra R, Faiz O, Munkholm P, Burisch J, Arebi N (2018) Epidemiology of inflammatory bowel disease in racial and ethnic migrant groups. World J Gastroenterol 24:424–437PubMedPubMedCentral

Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW et al (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142:46–54.e42, quiz e30PubMed

Moninuola OO, Milligan W, Lochhead P, Khalili H (2018) Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn’s disease and ulcerative colitis exacerbation. Aliment Pharmacol Ther 47:1428–1439PubMedPubMedCentral

Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V (1992) Incidence and prevalence of Crohn’s disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence. Scand J Gastroenterol 27:609–614PubMed

Munkholm P, Langholz E, Davidsen M, Binder V (1995) Disease activity courses in a regional cohort of Crohn’s disease patients. Scand J Gastroenterol 30:699–706PubMed

Nasiri S, Kuenzig ME, Benchimol EI (2017) Long-term outcomes of pediatric inflammatory bowel disease. Semin Pediatr Surg 26:398–404PubMed

Ng SC (2015) Emerging leadership lecture: inflammatory bowel disease in Asia: emergence of a “Western” disease. J Gastroenterol Hepatol 30:440–445PubMed

Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, Wong TC, Leung VK, Tsang SW, Yu HH et al (2013) Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology 145:158–165.e152PubMed

Ng SC, Zeng Z, Niewiadomski O, Tang W, Bell S, Kamm MA, Hu P, de Silva HJ, Niriella MA, Udara WS et al (2016) Early course of inflammatory bowel disease in a population-based inception cohort study from 8 countries in Asia and Australia. Gastroenterology 150:86–95, quiz e13–84PubMed

Ng SC, Kaplan GG, Tang W, Banerjee R, Adigopula B, Underwood FE, Tanyingoh D, Wei SC, Lin WC, Lin HH et al (2018a) Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia-Pacific. Am J Gastroenterol 15:39–49

Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL et al (2018b) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390:2769–2778PubMed

Nguyen GC, Bayless TM, Powe NR, Laveist TA, Brant SR (2007a) Race and health insurance are predictors of hospitalized Crohn’s disease patients undergoing bowel resection. Inflamm Bowel Dis 13:1408–1416PubMed

Nguyen GC, Tuskey A, Dassopoulos T, Harris ML, Brant SR (2007b) Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. IBD 13:1529–1535

Nie JY, Zhao Q (2017) Beverage consumption and risk of ulcerative colitis: systematic review and meta-analysis of epidemiological studies. Medicine 96:e9070PubMedPubMedCentral

Nunes T, Etchevers MJ, Garcia-Sanchez V, Ginard D, Marti E, Barreiro-de Acosta M, Gomollon F, Arroyo M, Bastida G, Gonzalez B et al (2016) Impact of smoking cessation on the clinical course of Crohn’s disease under current therapeutic algorithms: a multicenter prospective study. Am J Gastroenterol 111:411–419PubMed

Odes HS, Locker C, Neumann L, Zirkin HJ, Weizman Z, Sperber AD, Fraser GM, Krugliak P, Gaspar N, Eidelman L et al (1994) Epidemiology of Crohn’s disease in Southern Israel. Am J Gastroenterol 89:1859–1862PubMed

Olen O, Askling J, Sachs MC, Frumento P, Neovius M, Smedby KE, Ekbom A, Malmborg P, Ludvigsson JF (2017) Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964–2014. BMJ (Clinical research ed) 358:j3951

Opstelten JL, Beelen RMJ, Leenders M, Hoek G, Brunekreef B, van Schaik FDM, Siersema PD, Eriksen KT, Raaschou-Nielsen O, Tjonneland A et al (2016) Exposure to ambient air pollution and the risk of inflammatory bowel disease: a European nested case-control study. Dig Dis Sci 61:2963–2971PubMedPubMedCentral

Ortizo R, Lee SY, Nguyen ET, Jamal MM, Bechtold MM, Nguyen DL (2017) Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies. Eur J Gastroenterol Hepatol 29:1064–1070PubMed

Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Scholmerich J, Rogler G, Timmer A (2008) The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol 20:917–923PubMed

Papageorgiou SN, Hagner M, Nogueira AV, Franke A, Jager A, Deschner J (2017) Inflammatory bowel disease and oral health: systematic review and a meta-analysis. J Clin Periodontol 44:382–393PubMed

Pillai N, Dusheiko M, Burnand B, Pittet V (2017) A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease. PLoS ONE 12:e0185500PubMedPubMedCentral

Platz O (2018) Weißbuch Gastroenterologische Erkrankungen 2018/19 (E-Book). Z Gastroenterol 56:1173–1184

Porter CK, Welsh M, Riddle MS, Nieh C, Boyko EJ, Gackstetter G, Hooper TI (2017) Epidemiology of inflammatory bowel disease among participants of the Millennium Cohort: incidence, deployment-related risk factors, and antecedent episodes of infectious gastroenteritis. Aliment Pharmacol Ther 45:1115–1127PubMed

Prenzler A, Mittendorf T, Conrad S, von der Schulenburg JM, Bokemeyer B (2009) Costs of Crohn’s disease in Germany from the perspective of the Statutory Health Insurance. Z Gastroenterol 47:659–666PubMed

Prenzler A, Bokemeyer B, Mittendorf T, von der Schulenburg JM (2010) Costs of ulcerative colitis within the German Statutory Health Insurance. Dtsch Med Wochenschr 1946(135):281–286

Racine A, Carbonnel F, Chan SS, Hart AR, Bueno-de-Mesquita HB, Oldenburg B, van Schaik FD, Tjonneland A, Olsen A, Dahm CC et al (2016) Dietary patterns and risk of inflammatory bowel disease in Europe: results from the EPIC study. Inflamm Bowel Dis 22:345–354PubMed

Radon K, Windstetter D, Poluda AL, Mueller B, von Mutius E, Koletzko S (2007) Contact with farm animals in early life and juvenile inflammatory bowel disease: a case-control study. Pediatrics 120:354–361PubMed

Rivas MA, Avila BE, Koskela J, Huang H, Stevens C, Pirinen M, Haritunians T, Neale BM, Kurki M, Ganna A et al (2018) Insights into the genetic epidemiology of Crohn’s and rare diseases in the Ashkenazi Jewish population. PLoS Genet 14:e1007329PubMedPubMedCentral

Robertson DJ, Sandler RS (2001) Measles virus and Crohn’s disease: a critical appraisal of the current literature. Inflamm Bowel Dis 7:51–57PubMed

Russel MG, Volovics A, Schoon EJ, van Wijlick EH, Logan RF, Shivananda S, Stockbrugger RW (1998) Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 4:182–186PubMed

Sackett DL, Whelan G (1980) Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis. Gastroenterology 78:1632–1635PubMed

Salim SY, Kaplan GG, Madsen KL (2014) Air pollution effects on the gut microbiota: a link between exposure and inflammatory disease. Gut Microbes 5:215–219PubMed

Sandborn WJ (1999) Nicotine therapy for ulcerative colitis: a review of rationale, mechanisms, pharmacology, and clinical results. Am J Gastroenterol 94:1161–1171PubMed

Sartor RB (2005) Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease? Gut 54:896–898PubMedPubMedCentral

Schmidt S, Thyen U, Herrmann-Garitz C, Bomba F, Muehlan H (2016) The Youth Health Care measure-satisfaction, utilization, and needs (YHC-SUN)-development of a self-report version of the Child Health Care (CHC-SUN) proxy-measure. BMC Health Serv Res 16:189PubMedPubMedCentral

Sewell JL, Velayos FS (2013) Systematic review: the role of race and socioeconomic factors on IBD healthcare delivery and effectiveness. Inflamm Bowel Dis 19:627–643PubMedPubMedCentral

Shah SC, Khalili H, Gower-Rousseau C, Olen O, Benchimol EI, Lynge E, Nielsen KR, Brassard P, Vutcovici M, Bitton A et al (2018) Sex-based differences in incidence of inflammatory bowel diseases-pooled analysis of population-based studies from Western Countries. Gastroenterology 155:1079–1089.e1073PubMed

Shanahan F (2012) The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain. Nutr Rev 70(Suppl 1):S31–S37PubMed

Shaw SY, Blanchard JF, Bernstein CN (2015) Early childhood measles vaccinations are not associated with paediatric IBD: a population-based analysis. J Crohn’s Colitis 9:334–338

Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 39:690–697PubMedPubMedCentral

Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV Jr (2017) Incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Aliment Pharmacol Ther 15:857–863

Sigall-Boneh R, Levine A, Lomer M, Wierdsma N, Allan P, Fiorino G, Gatti S, Jonkers D, Kierkus J, Katsanos KH et al (2017) Research gaps in diet and nutrition in inflammatory bowel disease. A topical review by D-ECCO Working Group [Dietitians of ECCO]. J Crohn’s Colitis 11:1407–1419

Simillis C, Yamamoto T, Reese GE, Umegae S, Matsumoto K, Darzi AW, Tekkis PP (2008) A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol 103:196–205PubMed

Singh H, Nugent Z, Brownell M, Targownik LE, Roos LL, Bernstein CN (2015) Academic performance among children with inflamematory bowel disease: a population-based study. J Pediatr 166:1128–1133PubMed

Sonnenberg A (1989) Disability from inflammatory bowel disease among employees in West Germany. Gut 30:367–370PubMedPubMedCentral

Sonnenberg A (1990) Occupational distribution of inflammatory bowel disease among German employees. Gut 31:1037–1040PubMedPubMedCentral

Sonnenberg A (2007) Similar geographic variations in mortality from peptic ulcer and inflammatory bowel disease. IBD 13:763–768

Sonntag B, Stolze B, Heinecke A, Luegering A, Heidemann J, Lebiedz P, Rijcken E, Kiesel L, Domschke W, Kucharzik T et al (2007) Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life. IBD 13:1385–1390

Soon IS, Molodecky NA, Rabi DM, Ghali WA, Barkema HW, Kaplan GG (2012) The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol 12:51PubMedPubMedCentral

Spekhorst LM, Oldenburg B, van Bodegraven AA, de Jong DJ, Imhann F, van der Meulen-de Jong AE, Pierik MJ, van der Woude JC, Dijkstra G, D’Haens G et al (2017) Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease. World J Gastroenterol 23:8182–8192PubMedPubMedCentral

Stark R, K”nig HH, Leidl R (2006) Costs of inflammatory bowel disease in Germany. Pharmacoeconomics 24:797–814PubMed

Stein AC, Gaetano JN, Jacobs J, Kunnavakkam R, Bissonnette M, Pekow J (2016) Northern latitude but not season is associated with increased rates of hospitalizations related to inflammatory bowel disease: results of a multi-year analysis of a national cohort. PLoS ONE 11:e0161523PubMedPubMedCentral

Strisciuglio C, Giugliano F, Martinelli M, Cenni S, Greco L, Staiano A, Miele E (2017) Impact of environmental and familial factors in a cohort of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 64:569–574PubMed

Sturm A, Maaser C, Mendall M, Karagiannis D, Karatzas P, Ipenburg N, Sebastian S, Rizzello F, Limdi J, Katsanos K et al (2017) European Crohn’s and Colitis Organisation topical review on IBD in the elderly. J Crohn’s Colitis 11:263–273

Swaminath A, Feathers A, Ananthakrishnan AN, Falzon L, Li Ferry S (2017) Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn’s disease. Aliment Pharmacol Ther 46:645–656PubMedPubMedCentral

Theochari NA, Stefanopoulos A, Mylonas KS, Economopoulos KP (2018) Antibiotics exposure and risk of inflammatory bowel disease: a systematic review. Scand J Gastroenterol 53:1–7PubMed

Timmer A (2000) Gesundheitsökonomische Aspekte bei chronisch entzündlichen Darmerkrankungen [Health economical aspects of inflammatory bowel diseases]. Gesundh Ökon Qual Manag 5:54–66

Timmer A, Bauer A, Dignass A, Rogler G (2007) Sexual function in persons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol 5:87–94PubMed

To N, Gracie DJ, Ford AC (2016) Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn’s disease. Aliment Pharmacol Ther 43:549–561PubMed

Tuvlin JA, Raza SS, Bracamonte S, Julian C, Hanauer SB, Nicolae DL, King AC, Cho JH (2007) Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts. IBD 13:573–579

Urlep D, Blagus R, Orel R (2015) Incidence trends and geographical variability of pediatric inflammatory bowel disease in Slovenia: a nationwide study. Biomed Res Int 2015:921730PubMedPubMedCentral

van den Heuvel TRA, Jeuring SFG, Zeegers MP, van Dongen DHE, Wolters A, Masclee AAM, Hameeteman WH, Romberg-Camps MJL, Oostenbrug LE, Pierik MJ et al (2017) A 20-year temporal change analysis in incidence, presenting phenotype and mortality, in the Dutch IBDSL cohort-can diagnostic factors explain the increase in IBD incidence? J Crohn’s Colitis 11:1169–1179

van der Star BJ, van Dijk CE, Zock JP, Smit LAM, Baliatsas C, Heederik DJJ, Yzermans CJ (2018) Healthcare utilisation prior to the diagnosis of inflammatory bowel diseases and the influence of livestock exposure: a longitudinal case-control study. PLoS ONE 13:e0195305PubMedPubMedCentral

Vegh Z, Burisch J, Pedersen N, Kaimakliotis I, Duricova D, Bortlik M, Avnstrom S, Vinding KK, Olsen J, Nielsen KR et al (2014) Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. J Crohn’s Colitis 8:1506–1515

Vegh Z, Kurti Z, Lakatos PL (2017) Epidemiology of inflammatory bowel diseases from west to east. J Dig Dis 18:92–98PubMed

Wang F, Feng J, Gao Q, Ma M, Lin X, Liu J, Li J, Zhao Q (2017) Carbohydrate and protein intake and risk of ulcerative colitis: systematic review and dose-response meta-analysis of epidemiological studies. Clin Nutr (Edinburgh, Scotland) 36:1259–1265

Wardle RA, Wardle AJ, Charadva C, Ghosh S, Moran GW (2017) Literature review: impacts of socioeconomic status on the risk of inflammatory bowel disease and its outcomes. Eur J Gastroenterol Hepatol 29:879–884PubMed

Winter DA, Karolewska-Bochenek K, Lazowska-Przeorek I, Lionetti P, Mearin ML, Chong SK, Roma-Giannikou E, Maly J, Kolho KL, Shaoul R et al (2015) Pediatric IBD-unclassified is less common than previously reported; results of an 8-year audit of the EUROKIDS registry. Inflamm Bowel Dis 21:2145–2153PubMed

Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Bodini P, O’Morain C, Mouzas IA et al (2006a) Crohn’s disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort. Gut 55:510–518PubMedPubMedCentral

Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Langholz E, Bodini P, O’Morain C (2006b) Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study. Scand J Gastroenterol 41:46–54

Wyke RJ (1988) Capacity for work and employment record of patients with inflammatory bowel disease. Int Disabil Stud 10:176–179PubMed

Xu L, Lochhead P, Ko Y, Claggett B, Leong RW, Ananthakrishnan AN (2017) Systematic review with meta-analysis: breastfeeding and the risk of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther 46:780–789PubMedPubMedCentral

Yadav P, Ellinghaus D, Remy G, Freitag-Wolf S, Cesaro A, Degenhardt F, Boucher G, Delacre M, Peyrin-Biroulet L, Pichavant M et al (2017) Genetic factors interact with tobacco smoke to modify risk for inflammatory bowel disease in humans and mice. Gastroenterology 153:550–565PubMedPubMedCentral

Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP et al (2012) Human gut microbiome viewed across age and geography. Nature 486:222–227PubMedPubMedCentral

Zapata LB, Paulen ME, Cansino C, Marchbanks PA, Curtis KM (2010) Contraceptive use among women with inflammatory bowel disease: a systematic review. Contraception 82:72–85PubMed

Zeng L, Hu S, Chen P, Wei W, Tan Y (2017) Macronutrient intake and risk of Crohn’s disease: systematic review and dose-response meta-analysis of epidemiological studies. Nutrients 9(5):500PubMedCentral

Titel: Epidemiologie der chronisch-entzündlichen Darmerkrankungen
verfasst von: Antje Timmer
Verlag: Springer Berlin Heidelberg
Buch: Chronisch-entzündliche Darmerkrankungen
Print ISBN: 978-3-662-59103-1

Electronic ISBN: 978-3-662-59104-8

Copyright-Jahr: 2020
DOI: https://doi.org/10.1007/978-3-662-59104-8_2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Eingreifen von Umstehenden rettet vor Erstickungstod!

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen